K P Tsang, President, Hong Kong Alliance for Rare Diseases (HKARD)
K P Tsang, president of the Hong Kong Alliance for Rare Diseases (HKARD), shares the challenges faced by patients with rare diseases and their caregivers in Hong Kong, the areas…
GeneHarbor focuses on the development and manufacture of innovative biotech products, enzymes in particular, and enzymatic production of various highly value-added products. The company has developed a proprietary platform technology for production of various enzymes. The technology aims to reduce the cost & increase the life span of the enzymes. The Company also operates its own manufacturing facilities that industrially manufactures biochemicals of the highest standard.
Contact
Unit 507, 5/F, Bio-Informatics Centre, No. 2 Science Park West Avenue, Hong Kong Science Park, Pak Shek Kok, Hong Kong
Tel: +852 2838 0306
Website: http://www.geneharbortech.com.hk/index.htm
Email: info@geneharbor.com.hk
K P Tsang, president of the Hong Kong Alliance for Rare Diseases (HKARD), shares the challenges faced by patients with rare diseases and their caregivers in Hong Kong, the areas…
The Belun (magical) ring invented by a Hong Kong start-up helps you achieve a healthier night’s sleep without wasting valuable snooze time on going to the clinic. Anybody that struggles…
Xie Yuehui, chairman and CEO of Lifetech Scientific, one of Shenzhen’s leading medical devices companies, share the company’s focus on developing innovative minimally invasive interventional medical devices to global standards,…
Rupert Mok, a veteran of the Hong Kong medtech industry, discusses regulatory alignment between Hong Kong and mainland China, opportunities for collaboration, the consumer ‘wearable’ space, and the state of…
Ingrid Reinli, general manager of the European Chamber of Commerce in Hong Kong, discusses the chamber´s strategic priorities and how it serves to unify the European presence in the market.…
Lydia Leung, CEO of Belun Technology, introduces us to the start-up´s flagship product, the Belun Ring. She also discusses the impact that Artificial Intelligence (AI) and preventative care can have…
Merck Hong Kong’s Hee-sun Lee gives her first impressions of the Hong Kong market, her main priorities, upcoming product launches and tapping into the territory’s R&D ecosystem. Hee-sun, having joined…
Ir. Prof. Andros Chan, president of the Hong Kong Medical and Healthcare Device Industry Association (HKMHDIA), introduces the organization’s mandate, the emerging trends in Hong Kong medtech, and the impact…
The Hon. Fanny Law Fan Chiu-fun, chairperson, and Prof. Daniel Lee, head of the Biomedical Technology Cluster, at Hong Kong Science and Technology Parks Corporation (HKSTP) provide an update on Hong…
Small markets must inevitably etch out a niche positioning for themselves, and for Hong Kong, its world-class medical infrastructure, world-renowned academics and clinicians as well as high population density make…
Novartis Hong Kong general manager Dorine Leung and oncology head Sian Ng discuss the company’s restructuring, dividing the oncology business unit from the pharmaceutical division. In addition, they share their…
Joyce Wong, managing director for APAC at compliance solutions provider Polaris in Hong Kong, describes the company’s innovative solutions for its clients in the life sciences, the significance of basing…
See our Cookie Privacy Policy Here
